
51 - 200 employees
Founded 2020
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $111.8M Series A - Syncromune on 2024-12
Biotechnology • Pharmaceuticals • Healthcare
Syncromune is a clinical-stage company developing a novel intratumoral cancer immunotherapy platform called SYNC-T. The platform is designed to be delivered directly into target tumors to synchronize the immune system to recognize and destroy cancer throughout the body. Its lead investigational therapy, SV-102, is being evaluated in the LEGION-100 Phase 2 trial for metastatic castration-resistant prostate cancer. The company’s materials are directed at healthcare professionals and note that its compounds are investigational and not yet approved by regulatory authorities.
🔥 1 minute ago
Senior Director of Analytical Development overseeing analytical development for biological drug products. Collaborating with cross-functional teams for regulatory compliance and operational efficiency.
🇺🇸 United States – Remote
💵 $250k - $280k / year
💰 $111.8M Series A - Syncromune on 2024-12
⏰ Full Time
🟠 Senior
👔 Director
🔥 1 minute ago
Clinical Trial Manager overseeing oncology clinical trials from study start-up to closeout. Leading compliance with protocols and regulatory guidelines in a fast-paced environment.
🐊 Florida – Remote
💵 $145k - $165k / year
💰 $111.8M Series A - Syncromune on 2024-12
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧪 Clinical Research
🔥 1 minute ago
Associate Director overseeing analytical strategy for drug and product development across clinical phases. Responsible for compliance with regulatory requirements and leading cross-functional collaboration.
🇺🇸 United States – Remote
💵 $165k - $200k / year
💰 $111.8M Series A - Syncromune on 2024-12
⏰ Full Time
🟠 Senior
👔 Director
🗣️🇨🇳 Chinese Required